Sunil Kumar

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of biomolecular structure & dynamics

Molecular diversity

In silico pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Sunil Kumar, Iqra Ali, Faheem Abbas, Faiza Shafiq, Ashok Kumar Yadav, Manjunath D Ghate, Deepak Kumar
In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer. Molecular diversity (2024)
Sunil Kumar, Iqra Ali, Faheem Abbas, Nimra Khan, Manoj K Gupta, Manoj Garg, Saroj Kumar, Deepak Kumar
In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies. In silico pharmacology 11 (1) (2023)
Sunil Kumar, Sounok Sengupta, Iqra Ali, Manoj K Gupta, H Lalhlenmawia, Shavkatjon Azizov, Deepak Kumar
Identification and exploration of quinazoline-1,2,3-triazole inhibitors targeting EGFR in lung cancer. Journal of biomolecular structure & dynamics (2023)
Sunil Kumar, Monu Kumar Shukla, Abhishek Kumar Sharma, Gururaj K Jayaprakash, Rajiv K Tonk, Dinesh K Chellappan, Sachin Kumar Singh, Kamal Dua, Faheem Ahmed, Sanjib Bhattacharyya, Deepak Kumar
Metal-based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy. MedComm 4 (2) (2023)
Sunil Kumar, Iqra Ali, Faheem Abbas, Anurag Rana, Sadanand Pandey, Manoj Garg, Deepak Kumar
In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1,2,3-triazole hybrids as novel EGFR inhibitors targeting lung cancer. Journal of biomolecular structure & dynamics (2023)